Haloperidol

This page has not been fully approved by the PsychonautWiki administrators. It may contain incorrect information, particularly with respect to dosage, duration, subjective effects, toxicity and other risks. It may also not meet PW style and grammar standards.

Haloperidol
Chemical Nomenclature
Common names	Haldol
Substitutive name	Haloperidol
Systematic name	4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one
Class Membership
Psychoactive class	Antipsychotic
Chemical class	Butyrophenone / Phenylpiperidine
Routes of Administration
WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section. ⇣ Oral Dosage Bioavailability 60-70% Threshold 0.25 mg Light 0.25 - 1 mg Common 1 - 5 mg Strong 5 - 10 mg Heavy 10 mg + Duration Total 12 - 36 hours Onset 30 - 60 minutes DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.
Interactions

Summary sheet: Haloperidol

Haloperidol (trade name Haldol) is an antipsychotic drug used to treat Tourette Syndrome, as well as other mental disorders, such as schizophrenia, mania, bipolar disorder, delirium, psychosis as well a variety of other symptoms. It was first synthesized in 1958 by Paul Janssen from meperidine. Haloperidol is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system.

Chemistry

This chemistry section is incomplete. You can help by adding to it.

Pharmacology

This pharmacology section is incomplete. You can help by adding to it.

It is believed that 2C-H has little to no affinity for the 5-HT_2A receptor, thus lacking psychedelic effects. It does however, have affinity for the 5-HT_2C receptor, which is responsible for some stimulant effects.

See also

• Responsible use
• Antipsychotic
• Pethidine